ERVW-1 and Zika virus infectious disease: In conclusion, peptide Z2 from the stem region of ZIKV envelope protein exhibits potent anti-ZIKV activity, and excellent safety and pharmacological profiles, indicating its potential for further development as a novel antiviral drug to treat ZIKV infection in high-risk populations, particularly the pregnant women.